Article Excerpt: Biotech company MindBio Therapeutics (CSE:MBIO) filed a patent application for the world’s first AI model capable of detecting alcohol and drug use though vocal analysis.
The technology, vastly more efficient than typical breath and urine-based methods, uses more than 50 million data points to detect intoxication, promising widespread utility across industries where substance abuse testing in mandated by regulators, including mining, construction, law enforcement and aviation.
“The digital health diagnostics market represents a significant opportunity for MindBio to leverage its voice AI diagnostics technology with a first-mover commercialization advantage in drug and alcohol intoxication detection,” Justin Hanka, chief executive officer of MindBio Therapeutics, said…
Full Article: https://tinyurl.com/5c72psty
Article Source: MSN